ä¸äº¬å¥¥è¿ä¼å¼å¹ï¼âä½æ²é³ä¹+åµå°¸ç½æâå¼å槽ï¼ç½åï¼çåçäºï¼æ±å©·èµµå¸
å举å½æå
¥åºï¼è°è½æ¿ä¸å½æé¦é 2021-07-24 00:19:54ãæ¥æº: 21è´¢é»æ± ä¸¾æ¥ å享è³
å享è³å¥½ååæåå
第32å±å¤å£å¥¥æå¹å
è¿å¨ä¼å¼å¹å¼
äºå京æ¶é´23æ¥19ç¹å¨æ¥æ¬ä¸äº¬ä¸¾è¡
å¨å æ°å èºçç«æ
延æä¸å¹´å
ä¸äº¬å¥¥è¿ä¼éæ°èµ·èª
å¤åå
³æ³¨ï¼
è¿æ¯å¼å¹å¼ä¸çæ¼åºãæ°å社记è
åå°ç æ
å¼å¹å¼è¡¨æ¼
奥运冠军石智勇：相比五年前更有压力，目标再次夺金-中新网
chinanews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinanews.com Daily Mail and Mail on Sunday newspapers.
Chatter Between Cell Populations Drives Progression of Gastrointestinal Tumors
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Jason Sicklick, MD, professor of surgery at UC San Diego School of Medicine and surgical oncologist at UC San Diego Health. view more
Credit: UC San Diego Health Sciences
Gastrointestinal stromal tumors (GISTs) are a subytpe of cancers known as sarcomas. GIST is the most common type of sarcoma with approximately 5,000 to 6,000 new patient cases annually in the United States. GIST cannot be cured by drugs alone, and targeted therapies are only modestly effective, with a high rate of drug resistance. In a recent study, researchers at University of California San Diego School of Medicine and Moores Cancer Center identified new therapeutic targets that could lead to new treatment options for patients.